Published in J Virol on October 01, 1989
Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc Natl Acad Sci U S A (1991) 7.15
Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol (1991) 4.63
Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci U S A (1990) 4.12
In vitro processing of dengue virus type 2 nonstructural proteins NS2A, NS2B, and NS3. J Virol (1990) 3.50
Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites. J Virol (1991) 3.41
Hog cholera virus: molecular composition of virions from a pestivirus. J Virol (1991) 3.24
Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proc Natl Acad Sci U S A (1991) 2.97
Cleavage at a novel site in the NS4A region by the yellow fever virus NS2B-3 proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol (1993) 2.56
Cleavage of the dengue virus polyprotein at the NS3/NS4A and NS4B/NS5 junctions is mediated by viral protease NS2B-NS3, whereas NS4A/NS4B may be processed by a cellular protease. J Virol (1992) 2.33
NS2B-3 proteinase-mediated processing in the yellow fever virus structural region: in vitro and in vivo studies. J Virol (1994) 2.11
Deletion analysis of dengue virus type 4 nonstructural protein NS2B: identification of a domain required for NS2B-NS3 protease activity. J Virol (1993) 2.06
Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc Natl Acad Sci U S A (1993) 1.99
Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses. Proc Natl Acad Sci U S A (1992) 1.89
Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. J Virol (1992) 1.82
Cleavage of dengue virus NS1-NS2A requires an octapeptide sequence at the C terminus of NS1. J Virol (1990) 1.73
Processing of the intracellular form of the west Nile virus capsid protein by the viral NS2B-NS3 protease: an in vitro study. J Virol (1994) 1.42
Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus. J Virol (1992) 1.31
Posttranslational signal peptidase cleavage at the flavivirus C-prM junction in vitro. J Virol (1995) 1.27
Flavivirus enzyme-substrate interactions studied with chimeric proteinases: identification of an intragenic locus important for substrate recognition. J Virol (1991) 1.27
Formation of the flavivirus envelope: role of the viral NS2B-NS3 protease. J Virol (1995) 1.22
Upregulation of signalase processing and induction of prM-E secretion by the flavivirus NS2B-NS3 protease: roles of protease components. J Virol (1997) 1.06
Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera. Virol J (2011) 0.78
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
Supercoil sequencing: a fast and simple method for sequencing plasmid DNA. DNA (1985) 40.01
A new method for predicting signal sequence cleavage sites. Nucleic Acids Res (1986) 37.19
Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma. J Cell Biol (1975) 36.95
Signal sequences. The limits of variation. J Mol Biol (1985) 21.24
Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science (1985) 8.54
Mechanism of protein translocation across the endoplasmic reticulum membrane. Annu Rev Cell Biol (1986) 5.28
Nucleotide sequence and deduced amino acid sequence of the structural proteins of dengue type 2 virus, Jamaica genotype. Virology (1986) 4.34
Nucleotide and complete amino acid sequences of Kunjin virus: definitive gene order and characteristics of the virus-specified proteins. J Gen Virol (1988) 4.09
Flaviviridae. Intervirology (1985) 3.06
Primary structure of the West Nile flavivirus genome region coding for all nonstructural proteins. Virology (1986) 2.75
An internal signal sequence: the asialoglycoprotein receptor membrane anchor. Cell (1986) 2.74
Antigenic structure of the flavivirus envelope protein E at the molecular level, using tick-borne encephalitis virus as a model. J Virol (1989) 2.59
Bovine opsin has more than one signal sequence. Nature (1985) 2.54
The human glucose transporter can insert posttranslationally into microsomes. Cell (1986) 2.53
Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses. Virology (1988) 2.43
Nucleotide sequence and deduced amino acid sequence of the nonstructural proteins of dengue type 2 virus, Jamaica genotype: comparative analysis of the full-length genome. Virology (1988) 2.22
Gene mapping and positive identification of the non-structural proteins NS2A, NS2B, NS3, NS4B and NS5 of the flavivirus Kunjin and their cleavage sites. J Gen Virol (1988) 2.12
Sequence analysis of the viral core protein and the membrane-associated proteins V1 and NV2 of the flavivirus West Nile virus and of the genome sequence for these proteins. Virology (1985) 2.07
Using recombinant DNA techniques to study protein targeting in the eucaryotic cell. Annu Rev Cell Biol (1985) 2.07
Reinitiation of translocation in the Semliki Forest virus structural polyprotein: identification of the signal for the E1 glycoprotein. EMBO J (1986) 1.60
High genetic stability of the region coding for the structural proteins of yellow fever virus strain 17D. J Gen Virol (1987) 1.56
A former amino terminal signal sequence engineered to an internal location directs translocation of both flanking protein domains. J Cell Biol (1985) 1.54
Dengue virus-induced modifications of host cell membranes. J Virol (1975) 1.33
Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses. Virology (1986) 1.31
Distribution of dengue-2 antigens by electron immunocytochemistry. Infect Immun (1976) 1.29
Characterization of protease cleavage sites involved in the formation of the envelope glycoprotein and three non-structural proteins of dengue virus type 2, New Guinea C strain. J Gen Virol (1987) 1.26
Amino-terminal amino acid sequences of structural proteins of three flaviviruses. Virology (1985) 1.20
In vitro translation of 42 S virus-specific RNA from cells infected with the flavivirus West Nile virus. Virology (1979) 1.05
Identification of dengue type 2 virus-specific high molecular weight proteins in virus-infected BHK cells. J Gen Virol (1985) 1.04
Translation of tick-borne encephalitis virus (flavivirus) genome in vitro: synthesis of two structural polypeptides. Virology (1981) 1.01
Restricted translation of the genome of the flavivirus Kunjin in vitro. J Gen Virol (1982) 0.96
Modulations of the in vitro translational efficiencies of Yellow Fever virus mRNAs: interactions between coding and noncoding regions. Nucleic Acids Res (1989) 0.95
Amino acid compositions and amino-terminal sequences of the structural proteins of a flavivirus, European Tick-Borne Encephalitis virus. Virology (1983) 0.90
Comparative immunochemical and biological analysis of African and South American yellow fever viruses. Arch Virol (1987) 0.89
A tentative model of formation of structural proteins of tick-borne encephalitis virus (flavivirus). FEBS Lett (1986) 0.85
Dengue virus induced polypeptide synthesis. Brief report. Arch Virol (1985) 0.84
Expression of the yellow fever virus envelope protein using hybrid SV40/yellow fever viruses. Ann Inst Pasteur Virol (1989) 0.83
Characterization of novel viral polyproteins detected in cells infected by the flavivirus Kunjin and radiolabelled in the presence of the leucine analogue hydroxyleucine. J Gen Virol (1987) 0.79
A unique cap(m7GpppXm)-dependent influenza virion endonuclease cleaves capped RNAs to generate the primers that initiate viral RNA transcription. Cell (1981) 8.09
Aspects of the synthesis of poliovirus RNA and the formation of virus particles. Virology (1966) 5.85
HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature (1987) 5.45
Molecular weight of poliovirus ribonucleic acid. J Virol (1969) 5.16
Rapidly labeled HeLa cell nuclear RNA. I. Identification by zone sedimentation of a heterogeneous fraction separate from ribosomal precursor RNA. J Mol Biol (1966) 4.83
Globin mRNAs are primers for the transcription of influenza viral RNA in vitro. Proc Natl Acad Sci U S A (1978) 4.17
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65
Are the 5' ends of influenza viral mRNAs synthesized in vivo donated by host mRNAs? Cell (1979) 3.35
An intermediate in the synthesis of poliovirus RNA. Proc Natl Acad Sci U S A (1966) 3.24
Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro. Proc Natl Acad Sci U S A (1979) 3.10
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. Am J Trop Med Hyg (1995) 3.08
Capsid proteins of Simian virus 40. Biochem Biophys Res Commun (1970) 2.91
Rift Valley fever virus L segment: correction of the sequence and possible functional role of newly identified regions conserved in RNA-dependent polymerases. J Gen Virol (1994) 2.84
Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice. EMBO J (1988) 2.84
Both the 7-methyl and the 2'-O-methyl groups in the cap of mRNA strongly influence its ability to act as primer for influenza virus RNA transcription. Proc Natl Acad Sci U S A (1980) 2.56
A domain of SV40 capsid polypeptide VP1 that specifies migration into the cell nucleus. EMBO J (1986) 2.51
Genetic reassortment of Rift Valley fever virus in nature. J Virol (1999) 2.43
Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res (1997) 2.26
Role of myristoylation of poliovirus capsid protein VP4 as determined by site-directed mutagenesis of its N-terminal sequence. EMBO J (1989) 2.24
Programmed cell death and AIDS: significance of T-cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc Natl Acad Sci U S A (1994) 2.21
Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol (1986) 2.17
Early determinants of overweight at 4.5 years in a population-based longitudinal study. Int J Obes (Lond) (2006) 2.13
Percutaneous internal ureteral stent placement: review of technical issues and solutions in 50 consecutive cases. Clin Radiol (1994) 2.01
An improved method for sequencing of RNA templates. Nucleic Acids Res (1990) 1.99
Inhibitors of DNA synthesis: their influence on replication and transcription of simian virus 40 DNA. Virology (1974) 1.97
Cap and internal nucleotides of reovirus mRNA primers are incorporated into influenza viral complementary RNA during transcription in vitro. J Virol (1979) 1.95
Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1. Proc Natl Acad Sci U S A (1983) 1.94
High viral load in lymph nodes and latent human immunodeficiency virus (HIV) in peripheral blood cells of HIV-1-infected chimpanzees. J Virol (1993) 1.93
Improved antigenicity of the HIV env protein by cleavage site removal. Protein Eng (1988) 1.87
Picornavirus internal ribosome entry segments: comparison of translation efficiency and the requirements for optimal internal initiation of translation in vitro. Nucleic Acids Res (1995) 1.86
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice. J Virol (2000) 1.79
The L protein of Rift Valley fever virus can rescue viral ribonucleoproteins and transcribe synthetic genome-like RNA molecules. J Virol (1995) 1.77
Mapping of the mutations present in the genome of the Rift Valley fever virus attenuated MP12 strain and their putative role in attenuation. Virus Res (1997) 1.76
Ribosome formation in HeLa cells in the absence of protein synthesis. J Mol Biol (1966) 1.75
Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J (1991) 1.72
A novel, glycan-dependent epitope in the V2 domain of human immunodeficiency virus type 1 gp120 is recognized by a highly potent, neutralizing chimpanzee monoclonal antibody. J Virol (1994) 1.72
Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells. Science (1992) 1.71
Analysis of the functional significance of amino acid residues in the putative NTP-binding pattern of the poliovirus 2C protein. J Gen Virol (1992) 1.70
The effect of HeLa cell cytoplasm on the rate of sedimentation of RNA. Proc Natl Acad Sci U S A (1966) 1.69
Crimean-Congo hemorrhagic fever in Europe: current situation calls for preparedness. Euro Surveill (2010) 1.69
In vitro synthesis of poliovirus ribonucleic acid: role of the replicative intermediate. J Virol (1969) 1.68
Relationship between replication of simian virus 40 DNA and specific events of the host cell cycle. J Virol (1973) 1.67
Anatomy of the posterior approach to the lumbar plexus block. Can J Anaesth (1994) 1.62
A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1. EMBO J (1983) 1.59
Characterization of the 5' and 3' ends of viral messenger RNAs isolated from BHK21 cells infected with Germiston virus (Bunyavirus). Virology (1990) 1.59
Molecular cloning of the genome of poliovirus type 1. Proc Natl Acad Sci U S A (1981) 1.56
High genetic stability of the region coding for the structural proteins of yellow fever virus strain 17D. J Gen Virol (1987) 1.56
Quantitative real-time PCR detection of Rift Valley fever virus and its application to evaluation of antiviral compounds. J Clin Microbiol (2001) 1.56
Quinolines as potent 5-lipoxygenase inhibitors: synthesis and biological profile of L-746,530. Bioorg Med Chem Lett (1998) 1.54
Synoviorthesis with colloidal 32P chromic phosphate for the treatment of hemophilic arthropathy. J Bone Joint Surg Am (1994) 1.53
The addition of continuous intravenous infusion of ketorolac to a patient-controlled analgetic morphine regime reduced postoperative myocardial ischemia in patients undergoing elective total hip or knee arthroplasty. Anesth Analg (1997) 1.52
Facilitating submental endotracheal intubation with an endotracheal tube exchanger. Anesth Analg (2000) 1.49
Thermosensitive block of the Sabin strain of poliovirus type I. J Virol (1972) 1.48
Three-segment RNA genome of Lumbo virus (Bunyavirus). Intervirology (1973) 1.48
Selective inhibition of in vitro DNA synthesis dependent on phiX174 compared with fd DNA. I. Protein requirements for selective inhibition. J Biol Chem (1977) 1.47
Mercury levels in the Cree population of James Bay, Quebec, from 1988 to 1993/94. CMAJ (1998) 1.46
Human immunodeficiency virus type 1 neutralizing antibody serotyping using serum pools and an infectivity reduction assay. AIDS Res Hum Retroviruses (1996) 1.46
Studies on lumbo virus replication. I. RNA-dependent RNA polymerase associated with virions. Virology (1976) 1.46
Lack of myristoylation of poliovirus capsid polypeptide VP0 prevents the formation of virions or results in the assembly of noninfectious virus particles. J Virol (1990) 1.41
Meta-analysis on recombinant versus urinary follicle stimulating hormone. Hum Reprod (2000) 1.39
Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet (2001) 1.37
[Circular ribonucleoproteins in the virus Lumbo (Bunyavirus)]. C R Acad Sci Hebd Seances Acad Sci D (1975) 1.36
Variability of the NS(S) protein among Rift Valley fever virus isolates. J Gen Virol (1997) 1.36
Germiston virus transcriptase requires active 40S ribosomal subunits and utilizes capped cellular RNAs. J Virol (1992) 1.36
Action of the S1 endonuclease from Aspergillus oryzae on simian virus 40 supercoiled component I DNA. Biochem Biophys Res Commun (1973) 1.34
Single-tube and nested reverse transcriptase-polymerase chain reaction for detection of Rift Valley fever virus in human and animal sera. J Virol Methods (2001) 1.33
Music decreases sedative requirements during spinal anesthesia. Anesth Analg (2001) 1.32
A point mutation in the poliovirus polymerase gene determines a complementable temperature-sensitive defect of RNA replication. Virology (1989) 1.32
Genetic heterogeneity of yellow fever virus strains from Africa and the Americas. J Gen Virol (1986) 1.30
The intranuclear location of simian virus 40 polypeptides VP2 and VP3 depends on a specific amino acid sequence. J Virol (1987) 1.29
Testing the hypothesis of a recombinant origin of human immunodeficiency virus type 1 subtype E. J Virol (2000) 1.26
Use of type 1/type 2 chimeric polioviruses to study determinants of poliovirus type 1 neurovirulence in a mouse model. Virology (1991) 1.25
Stable secondary structures at the 3'-end of the genome of yellow fever virus (17 D vaccine strain). FEBS Lett (1985) 1.24
Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. J Virol (2009) 1.24
Origin of 1997-98 Rift Valley fever outbreak in East Africa. Lancet (1998) 1.24
Analysis of the glycosylation sites of hepatitis C virus (HCV) glycoprotein E1 and the influence of E1 glycans on the formation of the HCV glycoprotein complex. J Gen Virol (1999) 1.23
Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells. J Virol (2012) 1.23
Letter to the editor: In vivo incorporation of cytosine arabinoside into simian virus 40 DNA. J Mol Biol (1974) 1.22
Preschool children's eating behaviours are related to dietary adequacy and body weight. Eur J Clin Nutr (2006) 1.20
Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology (1997) 1.20
Use of cRNA probes for the detection of enteroviruses by molecular hybridization. J Med Virol (1988) 1.19
Analysis of the 3' terminal sequence recognized by the Rift Valley fever virus transcription complex in its ambisense S segment. Virology (1997) 1.19
Replication of simian virus 40 deoxyribonucleic acid: analysis of the one-step growth cycle. J Virol (1973) 1.18
Posterior approach to the lumbar plexus combined with a sciatic nerve block using lidocaine. Can J Anaesth (1994) 1.17
Transient increases in numbers of infectious cells in an HIV-infected chimpanzee following immune stimulation. AIDS Res Hum Retroviruses (1992) 1.17
Host range temperature-conditional mutants in the adenovirus DNA binding protein are defective in the assembly of infectious virus. Virology (1983) 1.16
Highly sensitive Taqman PCR detection of Puumala hantavirus. Microbes Infect (2001) 1.14
[Sem: a suitable statistical software adaptated for research in oncology]. Bull Cancer (2000) 1.14
Processing of the E1 glycoprotein of hepatitis C virus expressed in mammalian cells. J Gen Virol (1996) 1.14
Transformation by adenovirus early region 2A temperature-sensitive mutants and their revertants. Virology (1981) 1.13
Identification and characterization of a continuous neutralization epitope (C3) present on type 1 poliovirus. Prog Med Virol (1987) 1.11
Poliovirus chimeras expressing sequences from the principal neutralization domain of human immunodeficiency virus type 1. J Virol (1992) 1.11
Analysis of putative active site residues of the poliovirus 3C protease. Virology (1991) 1.11
The Rift Valley fever virus nonstructural protein NSs is phosphorylated at serine residues located in casein kinase II consensus motifs in the carboxy-terminus. Virology (1999) 1.09